The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

India's aggressive push to become a global sporting heavyweight could literally be weighed down by a population that is ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...

Research shows processed foods rewire your brain in just 5 days, creating powerful cravings and making weight loss harder.

A new study reveals that while the molecular structure of liver metabolism remains intact during starvation, obesity disrupts ...

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study ...

For true pet parents, life revolves around keeping their furry friends happy and healthy. But if meals aren't portioned to ...

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

Beef tallow is a soft, whitish solid resembling vegetable shortening or butter that is made by removing, simmering and ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.